Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 20Active not recruiting 19Completed 3Not yet recruiting 2Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Carcinoma 1

Interventions

Specimen Handling 24Biopsy 16Magnetic Resonance Spectroscopy 15Cyclophosphamide 5Bevacizumab 4Vincristine 3Taxes 3Prednisone 3Nivolumab 3Doxorubicin 3Cetuximab 3Azacitidine 3venetoclax 2trastuzumab deruxtecan 2prednylidene 2olaparib 2iadademstat 2deltacortene 2decitabine and cedazuridine drug combination 2X-Rays 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Practice Guidelines as Topic 2Paclitaxel 2Ipilimumab 2Immunoglobulin G 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × 1,2-diaminocyclohexaneplatinum II citrate × 30 days × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡